IOVA - Iovance Biotherapeutics Inc
IEX Last Trade
11.65
0.270 2.318%
Share volume: 3,960,271
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$11.38
0.27
2.37%
Summary score
22%
Profitability
25%
Dept financing
2%
Liquidity
49%
Performance
17%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-15.24%
Return on assets
-12.77%
Return on sales
0%
Return on invested capital
791.29%
Total debt ratio
6.61%
Debt ratio change over timeo
-0.99%
Current Ratio
20.61%
Quick Ratio
0%
Cash Position Ratio
10.96%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-18.03%
Return on assets
-16.07%
Return on sales
0%
Return on invested capital
652.78%
Total debt ratio
11.6%
Debt ratio change over timeo
-0.98%
Current Ratio
9.86%
Quick Ratio
0%
Cash Position Ratio
1.43%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-8.31%
Return on assets
-7.78%
Return on sales
0%
Return on invested capital
315.22%
Total debt ratio
7.25%
Debt ratio change over time
-0.99%
Current Ratio
14.25%
Quick Ratio
0%
Cash Position Ratio
2.93%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-102.7%
Return on assets
-102.56%
Return on sales
0%
Return on invested capital
1.9%
Total debt ratio
-98.67%
Debt ratio change over time
-0.99%
Current Ratio
2.77%
Quick Ratio
0%
Cash Position Ratio
0.95%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IOVA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -15.24% | -3.05% | 11.55% | 6.27% |
| Return on assets | -12.77% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 791.29% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 36% | 67% | 59% |
| Total debt ratio | 6.61% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.99% | 6.09% | 6.03% | 1.53% |
| Dept financing | 2% | 50% | 43% | 14% |
| Current Ratio | 9.86% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 1.43% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 14% | 31% | 30% |
| Short-term ratios | IOVA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -18.03% | -25.62% | 17.94% | 7.14% |
| Return on assets | -16.07% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 652.78% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 38% | 70% | 58% |
| Total debt ratio | 11.6% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.98% | -23.44% | 9.66% | 0.6% |
| Dept financing | 3% | 25% | 45% | 8% |
| Current Ratio | 9.86% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 1.43% | 1.48% | 0.76% | 1.49% |
| Liquididy | 49% | 47% | 33% | 59% |